alias:: Hypertensive Eye Disease
ICD-11_Code:: 9B60.0
tags:: disease, opthalmology, hypertension

- ## Etiology
  background-color:: blue
	- ### Causative Agents
		- Chronic systemic hypertension (primary or secondary)
	- ### Risk Factors
		- Uncontroleed Hypertension
		- Long duration of hypertension
		- Malignant hypertension (accelerated phase)
		- Diabetes Mellitus (compounding factor)
		- Smoking, obesity, hyperlipidemia
- ## Epidemiology
  background-color:: blue
	- ### Incidence
		- Increases with age and poorly controlled BP
	- ### Prevalence
		- ### Demographics
			- ~10-15% of hypertensive patients develop retinopathy
			- Higher in Black populations and low resource settings
	- ### Geographic Distribution
		- Global, higher in regions with poor hypertension management
- ## Pathophysiology
  background-color:: blue
	- ### Mechanism of Disease
		- Vasoconstriction -> vascular leakage, ischemia, and retinal damage
	- ### Affected Systems/Organs
		- Retina
		- Optic nerve (in severe cases)
- ## Clinical Features
  background-color:: blue
	- ### Clinical Presentation
		- #### Symptoms
			- Often asymptomatic early; advanced cases: blurred vision, headaches, vision loss
		- #### Signs
			- Fundoscopic findings
				- Anterior narrowing ("silver wiring"), AV nicking, flame hemorrhages, cotton wool spots, hard exudates, papilledema (malignant HTN)
	- ### Stages or Classification
		- **Grade I**: Mild arteriolar narrowing.
		- **Grade II**: AV nicking + focal constriction.
		- **Grade III**: Hemorrhages, exudates, cotton-wool spots.
		- **Grade IV**: Papilledema (malignant hypertension).
- ## Diagnosis
  background-color:: blue
	- ### Diagnostic Criteria
		- Fundoscopic findings + History of Hypertension
	- ### Investigation
		- ### Establishing Diagnosis
			- Fundoscopy (gold standard)
			- Optical coherence tomography for macular edema
			- Fluorescein angiography (if eschemia suspected)
		- ### Ruling Out Differential Diagnosis
			- |DD|Ruling Out|
			  |--|--|
			  |Diabetic Retinopathy|HbA1c, absence of microaneurysms|
			  |Retinal vein occlusion| Sudden painless vision loss, venous tortuosity|
			  |Papilledema(other causes) | MRI?LP for intracranial presssure|
		- ### General Assessment
- ## Management and Treatment
  background-color:: blue
	- ### Medical Treatment
		- Primary : Control systemic hypertension (ACE inhibitors, ARBs, calcium channel blockers)
		- Severe cases : Urgent BP reduction (avoid rapid drops in chronic HTN)
	- ### Surgical Options
		- None unless complications
			- vitrectomy for vitreous hemorrhage
	- ### Lifestyle and Dietary Recommendations
		- Salt restriction
		- Smoking cessation
		- Regular exercise
	- ### Follow-up
		- Annual eye exams for stable HTN
		- q3-6mo for retinopathy
- ## Prognosis
  background-color:: blue
	- ### Expected Course
		- #### With Treatment
			- Reversible in early stages; vision preserved with BP control
		- #### Without Treatment
			- ##### Possible Complications
				- Retinal detachment, macular edema, permanent vision loss
			- ##### Long-Term Effects
				- Increased Stroke and CVD risk
	- ### Survival Rates
		- #### With Treatment
		- #### Without Treatment
	- ### Quality of Life Considerations
- ## Prevention
  background-color:: blue
	- ### Screening Programs
		- Annual fundoscopy for Hypertensive patients
	- ### Lifestyle Modifications
		- BP monitoring
		- diet (DASH)
		- Weight management
- ## Patient Education and Support
  background-color:: blue
	- ### Educational Resources
	- ### Support Groups
	- ### Counseling Options
- ## Recent Research and Developments
  background-color:: blue
	- ### Ongoing Clinical Trials
	- Role of retinal biomarkers in predicting systemic CVD
	- ### Recent Advances
		- AI-assisted fundus imaging for early detection
- ## Key Literature
  background-color:: blue
- ## Guidelines and Protocols
  background-color:: blue